The Psychiatrist (1996) 20: 326-330. doi: 10.1192/pb.20.6.326
© 1996 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Krasucki, C.
Right arrow Articles by McFarlane, F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Krasucki, C.
Right arrow Articles by McFarlane, F.

Electrocardiograms, high-dose antipsychotic treatment and College guidelines

Christopher Krasucki, Registrar*

Maudsley Hospital, Denmark Hill, London SE5 8AZ

Fran McFarlane, Pharmacist

Bethlem Royal Hospital

* Correspondence

A cross-sectional survey of all in-patients at a psychiatric hospital was performed to see to what extent College guidelines on neuroleptic prescribing were being adhered to. Thirteen (7.3%) patients were found to be on high doses and one (0.6%) on megadoses. Only 23% in the high-dose group had had an ECG at all, and just 7.7% had had one in the previous three months. The single patient on megadose treatment had had an ECG but not in the previous three months. Prescribing habits that could potentially have led to 21.9% of patients receiving high doses and 9.0% megadoses were identified, and reasons for the low rate of ECGs discussed.




This article has been cited by other articles:


Home page
 Phil Trans R Soc BHome page
R. R Shah
Pharmacogenetics in drug regulation: promise, potential and pitfalls
Phil Trans R Soc B, August 29, 2005; 360(1460): 1617 - 1638.
[Abstract] [Full Text] [PDF]

Home page
 The PsychiatristHome page
M. Harrington, P. Lelliott, C. Paton, C. Okocha, R. Duffett, and T. Sensky
The results of a multi-centre audit of the prescribing of antipsychotic drugs for in-patients in the UK
The Psychiatrist, November 1, 2002; 26(11): 414 - 418.
[Abstract] [Full Text] [PDF]

Home page
 The PsychiatristHome page
G. Yorston and A. Pinney
Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high-dose antipsychotics
The Psychiatrist, April 1, 2000; 24(4): 130 - 132.
[Abstract] [Full Text]

Home page
 Br. J. PsychiatryHome page
S. A. SPENCE, P. M. GRASBY, P. F. LIDDLE, M. D. STEFAN, T. SHARMA, R. M. MURRAY, J. S. E. HELLEWELL, K. J. FRISTON, C. D. FRITH, S. R. HIRSCH, et al.
Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk: Focal dysfunction and distributed disconnectivity reappraised
The British Journal of Psychiatry, January 1, 2000; 176(1): 52 - 60.
[Abstract] [Full Text] [PDF]